Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2014
05/22/2014WO2014075155A1 Pharmaceutical combination containing an analgesic agent and an antispasmodic agent
05/22/2014WO2014051353A3 Microcapsule comprising glycoprotein derived from plants
05/22/2014WO2014009682A8 Improved apparatus and method for mineralising biological material
05/22/2014US20140142277 Cyclosporine analogue mixtures and their use as immunomodulating agents
05/22/2014US20140142187 Pharmaceutical Suspension Composition
05/22/2014US20140142183 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/22/2014US20140142177 Topical organic acid salt compositions suitable for treating infections
05/22/2014US20140142167 Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer
05/22/2014US20140142151 Allantoin-containing skin cream
05/22/2014US20140142124 Compositions for Topical Application Having Androgenic Actions
05/22/2014US20140142077 Androgen pharmaceutical composition and method for treating depression
05/22/2014US20140142076 Oral transmucosal drug delivery system
05/22/2014US20140142075 Methods and compositions for locally increasing body fat
05/22/2014US20140142070 Darunavir combination formulations
05/22/2014US20140142025 Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
05/22/2014US20140141092 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
05/22/2014US20140141091 Fexofenadine microcapsules and compositions containing them
05/22/2014US20140141090 Pharmaceutical Composition Comprising Opioid Agonist And Sequestered Antagonist
05/22/2014US20140141089 Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
05/22/2014US20140141088 Water-Soluble Anti-Inflammatory Cream with Natural Ingredients Base
05/22/2014US20140141087 Oral Composition Comprising An Antacid, an Anaesthetic and an Inorganic Matrix Comprising Silicon Dioxide and Titanium Dioxide
05/22/2014US20140141086 Injectable Depot Compositions and Uses Thereof
05/22/2014US20140141084 Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases
05/22/2014US20140141083 Nanoparticulate meloxicam formulations
05/22/2014US20140141080 Pharmaceutical compositions for the coordinated delivery of nsaids
05/22/2014US20140141079 Pramipexole once-daily dosage form
05/22/2014US20140141078 Dissolvable TableT
05/22/2014US20140141076 Soft capsule preparation, composition for soft capsule preparation, and method of producing soft capsule preparation
05/22/2014US20140141075 5-aminosalicylic acid capsule formulation
05/22/2014US20140141073 Anti-virus hydrophilic polymeric material
05/22/2014US20140141072 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
05/22/2014US20140141071 Orally administrable liposomally encapsulated reduced glutathione, with n-o enhancing compounds for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
05/22/2014US20140141070 Liposomes having useful n:p ratio for delivery of rna molecules
05/22/2014US20140141066 Encapsulated Ascorbic Acid Composition
05/22/2014US20140141060 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
05/22/2014US20140141059 Patch
05/22/2014US20140141056 Lidocaine-containing hydrogel patch
05/22/2014US20140141055 Manufacturing of semi-plastic pharmaceutical dosage units
05/22/2014US20140141053 Microlayer coextrusion to create a time-release drug substance delivery product
05/22/2014US20140141049 Method and composition for improving skin conditions comprising human placental lactogen as an active ingredient
05/22/2014US20140141008 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
05/22/2014US20140141007 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
05/22/2014US20140140974 Solubilized CoQ-10
05/22/2014US20140140937 Foamable Benzoyl Peroxide Compositions for Topical Administration
05/22/2014DE102013019286A1 Bonbon oder Kaugummi zur Lippenpflege und/oder -regeneration Candy or chewing gum for lip care and / or regeneration
05/22/2014DE102012221219A1 Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel A process for increasing the particle size of crystalline drug microparticles
05/22/2014DE102012111077A1 Optimierung von Vernebelungseigenschaften einer Lösung oder eines Kolloids Optimization of nebulization characteristics of a solution or a colloid
05/22/2014CA2851130A1 A pharmaceutical composition used for reducing damage caused by free radicals
05/21/2014EP2732832A2 Drug delivery device comprising an active compound and a thermo-sensitive polymeric material
05/21/2014EP2732818A1 A diphenylsulfonamide endothelin and angiotensin II receptor agonist to treat glomerulosclerosis
05/21/2014EP2732814A1 Integrating reconstituted membrane proteins into free-standing planar lipid bilayers
05/21/2014EP2732813A1 Orodispersible film compositions
05/21/2014EP2732812A1 Pramipexole retard tablet formulation
05/21/2014EP2732811A1 Method for producing a freeze-dried compound
05/21/2014EP2732810A1 Spherical particles of clopidogrel bisulfate, pharmaceutical composition including same, and method for manufacturing same
05/21/2014EP2731609A1 Nicotinamide compositions and the therapeutic use thereof
05/21/2014EP2731606A1 Gel compositions of oxymetazoline and methods of use
05/21/2014EP2731605A2 Pharmaceutical compositions for rectal administration
05/21/2014EP2731603A1 Stable dosage forms of arterolane and piperaquine
05/21/2014EP2731595A1 Use of xanthophyll carotenoids to improve visual performance and neural efficiency
05/21/2014EP2731594A1 Capsule formulation comprising montelukast and levocetirizine
05/21/2014EP2731593A2 A composition, device and method for delayed and sustained release of brain energy molecules
05/21/2014EP2731592A1 Controlled release pharmaceutical composition of non-ergoline dopamine agonist
05/21/2014EP2731591A2 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
05/21/2014EP2731590A1 Methods and apparatus for delivering a therapeutic agent to nasopharyngeal mucosa targets
05/21/2014EP2731589A1 A new therapeutical composition containing apomorphine as active ingredient
05/21/2014EP2731588A1 Composition and method for treating hpv
05/21/2014EP2731587A1 Intravaginal delivery system
05/21/2014EP2731586A1 Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
05/21/2014EP2731460A1 Formulation of transparent and nutritive microemulsions
05/21/2014CN203605454U 一种空气加热灭菌设备 An air heating and sterilizing equipment
05/21/2014CN203598256U 绑带式贴剂 Bandage-style patch
05/21/2014CN203598255U 可调节贴剂 Adjustable patch
05/21/2014CN203598254U 一种儿童止痛膏 A child analgesic cream
05/21/2014CN203598253U 一种方便折断的孟鲁斯特片 A convenient piece of broken Montelukast
05/21/2014CN203598252U 一种具有刻痕线的易于分成四份的片剂 Having a score line is divided into four parts is easy tablets
05/21/2014CN203598251U 一种多层隔离片剂 A multilayer tablet isolation
05/21/2014CN203598250U 一种双层包衣片剂 A two-layer coated tablets
05/21/2014CN203598249U 一种双层内包衣片剂 Within a two-layer coated tablets
05/21/2014CN103813807A 易服用性固体制剂 Easy to take solid preparations
05/21/2014CN103813806A 用于减少皮肤反应的新型稳定型麻醉剂组合物 Used to reduce skin reactions new stable anesthetic composition
05/21/2014CN103813798A 从罗望子树的种子获得的多糖聚合物在防止烟草相关的损伤中的用途 Polysaccharide polymer obtained from the seeds of tamarind tree in preventing tobacco-related injury in use
05/21/2014CN103813792A 用于治疗膀胱过度活动症的索利那新和唾液刺激剂的组合 That new combination for the treatment of Soli overactive bladder and saliva stimulating agents
05/21/2014CN103813787A 可溶胀的芯/壳型药片 Swellable core / shell type tablet
05/21/2014CN103813786A 用于局部递送的蛋白纳米载体 For topical delivery of a protein nanocarriers
05/21/2014CN103813785A 新的治疗阿片样物质依赖的抗滥用药物组合物 The new treatment of opioid-dependent anti-drug compositions
05/21/2014CN103813784A 控释鼻腔睾酮凝胶、用于经鼻给药的方法和预充式多剂量施药器系统 Controlled release nasal testosterone gel, a method for nasal administration and the pre-filled multi-dose administration system
05/21/2014CN103813783A 用于治疗眼部炎性病症的酯 For the treatment of ocular inflammatory disorders ester
05/21/2014CN103813766A 具有阀门的正压医用敷料和包含所述敷料的套件 Positive medical dressings have valves and kits comprising the dressing
05/21/2014CN103806087A 一种共载藤黄酸的新型TiO<sub>2</sub>纳米晶须材料的制备方法 Method for preparing a common carrier GA New TiO <sub> 2 </ sub> nanowhisker materials
05/21/2014CN103804458A 基于胆固醇的三种脂质材料的制备及其应用 Preparation and application of cholesterol-based lipid material in three
05/21/2014CN103800915A 一种靶向整合素受体的联合载药胶束及其制备方法 A drug-loaded micelles targeted integration combined hormone receptor and its preparation method
05/21/2014CN103800912A 一种稳定的软胶囊囊壳及其制备方法 A stabilized capsule shell soft capsule and its preparation method
05/21/2014CN103800911A 可消除peg化纳米载体abc现象的方法 The method can eliminate the peg of nanocarriers abc phenomenon
05/21/2014CN103800907A 一种耐冻融乳剂平台 One kind of freeze-thaw resistance emulsion platform
05/21/2014CN103800906A 用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物 Compositions for stimulating the mammalian innate immune resistance to pathogens of
05/21/2014CN103800884A 一种蛇胆陈皮口服液的制备方法 One kind of gall bladder Citrus oral preparation
05/21/2014CN103800882A 一种具有波浪热能自动传变的灸疗药膏及其制备方法 A wave of heat moxibustion ointment automatic transmission variant of its preparation method
05/21/2014CN103800879A 一种天然生乌发颗粒及其制备方法 A natural born UFA particles and preparation method
05/21/2014CN103800874A 一种熏蒸治疗脑中风偏瘫肢体功能障碍的药物组合物 One kind of fumigation treatment of stroke hemiplegic limb dysfunction pharmaceutical composition
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 2991